MLSS
Milestone Scientific·AMEX
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 0
Consensus Rating "Strong Buy"
Ample Liquidity
High Gross Profit Margin
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About MLSS
Milestone Scientific Inc.
A leading developer of computerized drug delivery instruments that provides painless and precise injections
Healthcare Equipment and Supplies
--
06/01/2015
American Stock Exchange
17
12-31
Common stock
425 Eagle Rock Avenue, Roseland, NJ 07068
--
Milestone Scientific Inc., was incorporated in Delaware in August 1989. The company has developed a proprietary, revolutionary, computer-controlled anesthesia drug delivery device with its DPS Dynamic Pressure Sensing Technology System to meet the needs of a variety of subcutaneous drug delivery injections and liquid inhalation — enabling healthcare practitioners to realize multiple unique benefits that are currently unavailable with manual syringes that have been used for 160 years.
Company Financials
EPS
MLSS has released its 2025 Q3 earnings. EPS was reported at -0.01, versus the expected -0.01, meeting expectations. The chart below visualizes how MLSS has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
MLSS has released its 2025 Q3 earnings report, with revenue of 2.36M, reflecting a YoY change of -6.11%, and net profit of -1.15M, showing a YoY change of 21.03%. The Sankey diagram below clearly presents MLSS's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
